Cargando…

Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry

Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulin, N., Frost, A., Carraro, A., Mommers, E., Guillaud, M., van Diest, P.J., Grizzle, W., Beenken, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618986/
https://www.ncbi.nlm.nih.gov/pubmed/12775917
http://dx.doi.org/10.1155/2003/262918
_version_ 1782397015379935232
author Poulin, N.
Frost, A.
Carraro, A.
Mommers, E.
Guillaud, M.
van Diest, P.J.
Grizzle, W.
Beenken, S.
author_facet Poulin, N.
Frost, A.
Carraro, A.
Mommers, E.
Guillaud, M.
van Diest, P.J.
Grizzle, W.
Beenken, S.
author_sort Poulin, N.
collection PubMed
description Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast neoplasia. Nuclear features are derived from computerized analysis of digitized microscope images, and a quantitative Feulgen stain for DNA was used. Features analyzed included: (1) DNA content; (2) nuclear size and shape; and (3) texture features, describing spatial features of chromatin distribution. In this study replicated measurements are described on a series of 54 breast carcinoma specimens of differing pathologic grades. Duplicate measurements were performed using two serial sections, which were processed and analyzed separately. The value of a single feature measurement, the nuclear area profile, was shown to be the strongest indicator of progression. A quantitative nuclear grade was derived and shown to be strongly correlated with not only the pathologic nuclear grade, but also with tubule formation, mitotic grade, and with the overall histopathologic grade. Analysis of replication precision showed that the standard methods of the histopathology laboratory, if practiced in a uniform manner, are sufficient to ensure reproducibility of these assessments. We argue that nuclear morphometry provides a standardized and reproducible framework for quantitative pathologic assessments.
format Online
Article
Text
id pubmed-4618986
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-46189862016-01-12 Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry Poulin, N. Frost, A. Carraro, A. Mommers, E. Guillaud, M. van Diest, P.J. Grizzle, W. Beenken, S. Anal Cell Pathol Other Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast neoplasia. Nuclear features are derived from computerized analysis of digitized microscope images, and a quantitative Feulgen stain for DNA was used. Features analyzed included: (1) DNA content; (2) nuclear size and shape; and (3) texture features, describing spatial features of chromatin distribution. In this study replicated measurements are described on a series of 54 breast carcinoma specimens of differing pathologic grades. Duplicate measurements were performed using two serial sections, which were processed and analyzed separately. The value of a single feature measurement, the nuclear area profile, was shown to be the strongest indicator of progression. A quantitative nuclear grade was derived and shown to be strongly correlated with not only the pathologic nuclear grade, but also with tubule formation, mitotic grade, and with the overall histopathologic grade. Analysis of replication precision showed that the standard methods of the histopathology laboratory, if practiced in a uniform manner, are sufficient to ensure reproducibility of these assessments. We argue that nuclear morphometry provides a standardized and reproducible framework for quantitative pathologic assessments. IOS Press 2003 2003-01-01 /pmc/articles/PMC4618986/ /pubmed/12775917 http://dx.doi.org/10.1155/2003/262918 Text en Copyright © 2003 Hindawi Publishing Corporation.
spellingShingle Other
Poulin, N.
Frost, A.
Carraro, A.
Mommers, E.
Guillaud, M.
van Diest, P.J.
Grizzle, W.
Beenken, S.
Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_full Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_fullStr Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_full_unstemmed Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_short Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_sort risk biomarker assessment for breast cancer progression: replication precision of nuclear morphometry
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618986/
https://www.ncbi.nlm.nih.gov/pubmed/12775917
http://dx.doi.org/10.1155/2003/262918
work_keys_str_mv AT poulinn riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT frosta riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT carraroa riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT mommerse riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT guillaudm riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT vandiestpj riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT grizzlew riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT beenkens riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry